Virus-free modification of iPSCs with our iTOP technology.
With iTOP we can deliver native proteins in to cells using a natural cellular uptake pathway. We will further develop and optimize our iTOP technology to allow efficient intracellular delivery of gene- or epigenetic modifying enzymes into (differentiating) iPSCs.
It feels good to have a shared goal with such a large group of different people. I think consortia can speed up the search for treatments
That it brings ideas together of research groups of different areas and companies.